Source: Frontiers in Pharmacology. Unidades: FM, IQ
Subjects: ADENOSINA, CÉLULAS-TRONCO, CAFEÍNA
ABNT
GLASER, Talita et al. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, v. 14, p. 1-16 art. 1328398, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fphar.2023.1328398. Acesso em: 01 nov. 2024.APA
Glaser, T., Martins, P., Beco, R., Bento, C. A., Cappellari, A. R., Oliveira, S. L. B. de, et al. (2024). Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms. Frontiers in Pharmacology, 14, 1-16 art. 1328398. doi:10.3389/fphar.2023.1328398NLM
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398Vancouver
Glaser T, Martins P, Beco R, Bento CA, Cappellari AR, Oliveira SLB de, Merkel CA, Sampaio VFA, Lameu C, Battastini AM, Ulrich H. Impairment of adenosine signaling disrupts early embryo development: unveiling the underlying mechanisms [Internet]. Frontiers in Pharmacology. 2024 ; 14 1-16 art. 1328398.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1328398